James Sapirstein First Wave Bio Pharma, Inc. (FWBI) insider trading activity

James Sapirstein is Chairman and CEO of First Wave BioPharma, Inc.. Currently has a direct ownership of 35,816 shares of FWBI, which is worth approximately $35,457. The most recent transaction as insider was on Jul 02, 2024, when has been sold 1,289 shares (Common Stock) at a price of $1.07 per share, resulting in proceeds of $1,379. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.8K

0% 3M change

7.24% 12M change

Total Value Held $35,457

JAMES SAPIRSTEIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 02 2024	SELL Open market or private sale	$1,379 $1.07 p/Share	1,289 Reduced 3.47%	35,816 Common Stock
Apr 01 2024	SELL Open market or private sale	$736 $4.23 p/Share	174 Reduced 0.47%	37,105 Common Stock
Mar 15 2024	SELL Open market or private sale	$9,359 $4.96 p/Share	1,887 Reduced 4.82%	37,279 Common Stock
Jan 12 2024	SELL Open market or private sale	$697 $4.2 p/Share	166 Reduced 0.42%	39,166 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	20,000 Added 33.71%	39,332 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	-	17,660 Added 47.74%	19,332 Common Stock
Oct 04 2023	SELL Open market or private sale	$801 $0.29 p/Share	2,764 Reduced 7.64%	33,397 Common Stock
Jul 03 2023	SELL Open market or private sale	$5,157 $1.54 p/Share	3,349 Reduced 8.48%	36,161 Common Stock
Apr 03 2023	SELL Open market or private sale	$8,367 $2.5 p/Share	3,347 Reduced 7.81%	39,510 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	300,000 Added 50.0%	300,000 Common Stock

Also insider at

ENOB

Enochian Biosciences Inc Healthcare

Director

MRZM

MARIZYME INC Healthcare

Interim CEO

LSPR

Larkspur Health Acquisition Corp. Financial Services

Director

BWV

Blue Water Vaccines Inc. Healthcare

Director